AIM ImmunoTech Inc. Logo

AIM ImmunoTech Inc.

Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.

AIM | US

Overview

Corporate Details

ISIN(s):
US42366C3016
LEI:
Country:
United States of America
Address:
2117 SW HIGHWAY 484, 32801 OCALA

Description

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics for various diseases. The company's primary areas of focus include oncology, immune disorders, and viral diseases. Its lead drug candidate is Ampligen® (rintatolimod), a proprietary immuno-modulator with broad-spectrum activity demonstrated in pre-clinical testing. Ampligen® is being evaluated in multiple clinical studies for a range of debilitating and life-threatening conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-17 17:30
8-K
English ZIP 69.7 KB
2025-12-11 19:21
S-1
English ZIP 270.2 KB
2025-11-19 08:00
8-K
English ZIP 195.6 KB
2025-11-17 17:36
10-Q
English ZIP 1.5 MB
2025-11-17 07:07
NT 10-Q
English ZIP 16.1 KB
2025-10-30 18:00
424B5
English ZIP 110.1 KB
2025-10-29 18:16
8-K
English ZIP 101.6 MB
2025-10-29 17:30
DEF 14A
English ZIP 7.2 MB
2025-10-20 11:16
8-K
English ZIP 12.8 MB
2025-08-14 18:15
10-Q
English ZIP 1.3 MB
2025-07-31 18:45
8-K
English ZIP 584.3 KB
2025-07-30 08:30
424B5
English ZIP 114.7 KB
2025-07-29 02:15 English ZIP 5.2 KB
2025-07-28 11:20
8-K
English ZIP 119.6 KB
2025-07-24 16:46 English ZIP 7.4 KB

Automate Your Workflow. Get a real-time feed of all AIM ImmunoTech Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AIM ImmunoTech Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AIM ImmunoTech Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.